Varicella-specific immunoglobulin G titers in commercial intravenous immunoglobulin preparations

Pediatrics

Volumn 124, Issue 3, 2009, Pages

  Maranich, Ashley M ^a,b   Rajnik, Michael ^a  

^a Uniformed Services University of the Health Sciences   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Intravenous immunoglobulin; Vaccination; Varicella zoster virus

Indexed keywords

CARIMUNE; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; PRIORITY JOURNAL; RISK FACTOR; VARICELLA ZOSTER VIRUS;

CHICKENPOX; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; PHARMACEUTICAL PREPARATIONS;

EID: 70349237825     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-0047     Document Type: Article

References (9)

1. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1996;45(RR-11):1-36
2. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002;287(5):606-611
3. American Academy of Pediatrics. Varicella zoster infections. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:711-725
4. Brunell PA, Ross A, Miller LH, et al. Prevention of varicella by zoster immune globulin. N Engl J Med. 1969;280(22):1191-1194
5. Brunell PA, Gershon AA, Hughes WT, et al. Prevention of varicella in high risk children: a collaborative study. Pediatrics. 1972;50(5):718-722
6. Lemm G. Composition and properties of IVIg preparations that affect tolerability and therapeutic efficacy. Neurology. 2002;59(12 suppl 6):S28-S32 (Pubitemid 36076546)
7. Marin M, Guris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40
8. Audet S, Virata-Theimer ML, Beeler JA, et al. Measles-virus-neutralizing antibodies in intravenous immunoglobulins. J Infect Dis. 2006;194(6):781-789
9. Paryani SG, Arvin AM, Koropchak CM, et al. Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin. Am J Med. 1984;76(3A): 124-127 (Pubitemid 14126161)